Anzeige
Mehr »
Freitag, 03.10.2025 - Börsentäglich über 12.000 News
Golden Cross macht sich bereit: 1.350 Goldabbaustellen, 55 Ladder-Ziele und ein historischer Volltreffer
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41DDP | ISIN: SE0025420714 | Ticker-Symbol: 3F80
Frankfurt
03.10.25 | 08:21
2,500 Euro
-2,15 % -0,055
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
Q-LINEA AB Chart 1 Jahr
5-Tage-Chart
Q-LINEA AB 5-Tage-Chart
RealtimeGeldBriefZeit
2,5202,71014:50

Aktuelle News zur Q-LINEA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10:00Q-Linea AB: US Trauma Center signs commercial contract 118Q-linea AB (publ) (OMX: QLINEA) announces adoption of the first Accelerate Pheno conversion to the ASTar system by a prominent US level 1 University Hospital Trauma Center. The University hospital selected...
► Artikel lesen
18.09.Q-Linea AB: Q-linea | Letter from the CEO101Q-linea AB (publ) (OMX: QLINEA) today shared a Company update. Key messagesReiterating target of 30 - 40 ASTar units contracted by end of year 2025 with outlook for 100 - 120 by end of 2026 and exceeding...
► Artikel lesen
18.09.Q-Linea AB: Q-linea resolves to carry out a rights issue of approximately SEK 322 million and announces terms169Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA), announces that the board of directors today has resolved to carry out a share issue of approximately SEK 322 million with preferential...
► Artikel lesen
05.09.Q-Linea AB: Q-linea to initiate new clinical evaluations of ASTar in the GCC region302Q-linea AB (Publ) (OMX: QLINEA) announces 2 new clinical evaluations of ASTar in Saudi Arabia and Kuwait. Q-linea, through the distributor partner AMICO Group, is moving into clinical evaluation of...
► Artikel lesen
14.07.XFRA NEW INSTRUMENTS AVAILABLE ON 14.07.2025453The following instruments on XETRA do have their first trading 14.07.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 14.07.2025 Aktien 1 PLK2ITR00010 Fabrity S.A. 2 SE0013512506...
► Artikel lesen
Q-LINEA Aktie jetzt für 0€ handeln
11.07.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 11.07.2025513The following instruments on Boerse Frankfurt do have their last trading day on 11.07.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 11.07.2025ISIN NameCA1394811055 CAPE...
► Artikel lesen
11.07.XFRA ISIN CHANGE345Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS52110H1005 Lazydays Holdings Inc. 11.07.2025 US52110H2094 Lazydays Holdings Inc. 14.07.2025 Tausch 30:1US08862L1035 Beyond...
► Artikel lesen
11.07.XFRA CAPITAL ADJUSTMENT INFORMATION - 11.07.2025454Das Instrument 7HW SE0015812516 WYLD NETWORKS AB EQUITY wird cum Kapitalmassnahme gehandelt am 11.07.2025 und ex Kapitalmassnahme am 14.07.2025 The instrument 7HW SE0015812516 WYLD NETWORKS AB EQUITY...
► Artikel lesen
10.07.Q-Linea AB: Interim report 1 January - 30 June 2025221Mid-year performance on track for 2025 plan The quarter April - June 2025Net sales amounted to SEK 1.1 (0.2) million.Operating result (EBIT) of SEK -47.3 (-65.3) million.Profit after tax amounted to...
► Artikel lesen
09.07.Split and Change of ISIN for Q-Linea AB268The company will carry out a reverse stock split in relations 1:1000. The share will be traded under new ISIN code with effect from July 14, 2025. The order book will not change. Short...
► Artikel lesen
08.07.Q-Linea AB: Q-linea AB announces timetable for reverse share split215At the annual general meeting of Q-linea AB (publ) (the "Company") on 26 June 2025, it was resolved to carry out a reverse share split of 1:1000, entailing that one thousand (1000) shares will be combined...
► Artikel lesen
19.06.Q-Linea AB: Q-linea on track for 2025 plan452Q-linea AB (publ) (OMX: QLINEA) today shared a Company and Market update. Key messagesQ2 instrument placements: Five newly-contracted units were placed, bringing the total to 14 YTD (2024: 4, Q1 2025:...
► Artikel lesen
23.05.Q-Linea AB: Q-linea's board of directors proposes a reverse share split and a reduction of the share capital281The board of directors of Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA) proposes that the annual general meeting on 26 June 2025 resolves on a reverse share split where 1...
► Artikel lesen
14.04.Q-Linea AB: Interim report 1 January - 31 March 2025306Strong start to the year with accelerating momentum First quarter: 1 January-31 March 2025Five customer contracts were signed during the quarter, three of which were in the US.Total of 9 ASTar units...
► Artikel lesen
25.03.Q-Linea AB: Q-linea announces tender win in Italy245Q-linea AB (publ) (OMX: QLINEA) today announces the awarding of a rapid AST tender for the Naples region. Q-linea's ASTar® platform has been selected to provide rapid AST for a network of hospitals...
► Artikel lesen
18.03.Q-Linea AB: Q-linea anticipates accelerating ASTar placements through 2025 and 2026 driving revenue growth392Q-linea AB (publ) (OMX: QLINEA) today shared a Company and Market update. Key messagesAnticipate total contracts for 30 - 40 ASTar instruments by end-2025; roughly 50% in USAdditional placements of...
► Artikel lesen
28.02.Q-Linea AB: Year-end report 1 January - 31 December 2024289Rights issue of SEK 225 million Fourth quarter: 1 October - 31 December 2024Net sales amounted to SEK 0.2 million (0.1).The operating result totalled SEK -51.3 million (-55.4).The result for the period...
► Artikel lesen
05.02.Q-Linea AB: Q-linea awarded first public tender in Belgium334Q-linea AB (publ) (OMX: QLINEA) today announces that the company has been awarded the tender at Cliniques Universitaires Saint-Luc in Brussels, Belgium for the ASTar® Instrument and Consumables through...
► Artikel lesen
31.01.Q-Linea AB: Q-linea announces preliminary outcome of the rights issue629Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA) announces the preliminary outcome of the Company's rights issue of approximately SEK 225 (the "Rights Issue"), for which the...
► Artikel lesen
24.01.Q-Linea AB: Continued commercial progress with US reference laboratory792Q-linea AB (publ) (OMX: QLINEA) today announces contract negotiations continue between Q-linea, Inc. and a large US reference laboratory, with an agreement anticipated in February 2025. Initial sites...
► Artikel lesen
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2